Press Releases August 25, 2026 04:30 PM

BJ’s Restaurants, Inc. to Participate at the 19th Annual Barclays Global Consumer Staples Conference

BJ's Restaurants, Inc. to Present at Barclays Global Consumer Staples Conference Sept. 8

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
BJRI

BJ's Restaurants, Inc. announced that its management team will participate in a fireside discussion at the 19th Annual Barclays Global Consumer Staples Conference in Boston on September 8, 2026. The event will be webcast live and rebroadcast on the company's investor relations website. BJ's Restaurants is a national casual dining brand known for its craft brews and signature menu items with over 200 locations across 31 states.

BJ’s Restaurants, Inc. to Participate at the 19th Annual Barclays Global Consumer Staples Conference
BJRI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • BJ's Restaurants will participate in a key consumer staples investor conference, enhancing visibility among investors.
  • The company operates over 200 casual dining restaurants across 31 U.S. states, highlighting its national footprint.
  • BJ's is recognized for its craft brewing program, having won over 270 medals including recent prestigious awards in 2025 and 2026.
  • Sectors impacted include Consumer Discretionary, specifically the Restaurants and Breweries industries, and the broader Consumer Staples market through the conference focus.

HUNTINGTON BEACH, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) announced today that management will be participating at the 19th Annual Barclays Global Consumer Staples Conference on Tuesday, September 8, 2026. The Company will participate in a fireside discussion, which will be held at the Intercontinental hotel in Boston, Massachusetts.

A live webcast of the discussion will be available on the “Investors” page of the Company’s website located at https://investors.bjsrestaurants.com. A replay will be archived and available at the same location.

About BJ’s Restaurants, Inc.

Founded in 1978, BJ's Restaurants, Inc. is a national casual dining brand with deep brewhouse roots delivering premium food and memorable experiences. With more than 200 restaurants across 31 states, BJ's brings guests together to celebrate life's everyday moments over chef-crafted food, award-winning house crafted beer and genuine hospitality in a fresh atmosphere. With signature deep-dish pizzas, the often imitated but never replicated world-famous Pizookie® dessert, pours and more, BJ's offers something for every taste and every occasion. A pioneer in craft brewing, BJ's is the most decorated restaurant-brewery in the country, earning over 270 medals since 1996, including the 2025 Questex Vibe Vista Award for Best Beer Program and top rankings across multiple categories at the 2026 World Beer Cup and North American Beer Awards. Whether gathering with family for a weeknight dinner, catching the game with friends or raising a glass to life's biggest milestones, BJ's is where moments turn into lasting memories. To learn more, visit www.bjsrestaurants.com or follow @bjsrestaurants on Instagram, Facebook and X.

For further information, please contact ICR at (332) 242-4370 or at InvestorRelations@BJRI.com.


Risks

  • The announcement is primarily an investor relations event with no new operational or financial guidance, which may temper market enthusiasm.
  • The company's growth and performance could be impacted by broader economic conditions affecting discretionary consumer spending and dining out trends.
  • Competitive pressures in the casual dining and craft beer segments represent ongoing operational risks.

More from Press Releases

LGI Homes, Inc. Reports August 2026 Home Closings Sep 3, 2026 Micware Launches Growth Strategy Connecting Mobility and Digital Spaces with AI at its Core Sep 3, 2026 DSS, Inc. Announces Launch of Proposed Public Offering Sep 3, 2026 H World Group Limited Announces Proposed Offering of CNY-denominated Bonds Sep 3, 2026 Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) Sep 3, 2026